Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
23ANE Wojcicki, Washington, DC, on June 10, 2025, talks during a home committee on a supervision and government reform meeting in Washington.
Andrew Harnik | Getty pictures
23AndMe co-founder and former General Director Anne Wojcicki, a new non-profit, the EMBattled Genetic Test Company resumed control after the TTAM Research Institute Rejeneron Pharmacycompany declared Friday.
TTAM will receive 238 million dollars for $ 305 million, as well as personal genome services and research services for business lines, as well as telehialt assistant lumonaid health. 23andMe is a great victory for Wojcicki who is stated from the role Presented for chapter 11 Bankruptcy protection in March.
Last month, Regeneron announced that the assets of 23And after the bankruptcy auction will receive more than $ 256 million. However, Wojcicki presented $ 305 million in the offer through the TTAM and encouraged the auction to reopen the auction. Ttam has an abbreviation for the first letters of 23andme Wall Street Journal.
“The human genome of the TTAM Research Institute will be able to continue 23Andme mission to use, understand and benefit from human genome,” he said.
23antme, DNA test sets at home, gave information about customers’ family history and genetic profiles. Five times CNBC disruptive 50 company went to the public Through a combination with a special purpose company in 2021. At its peak, 23Andme was estimated at about $ 6 billion.
After the company’s repetitive income and public access, live research and therapeutic enterprises fought to stand up and faced privacy concerns from today Hackers got information About seven million customers in 2023.
TTAM’s acquisition should still be approved by the US bankrupt court in the Eastern district of Missouri.
